BEG Nasal Spray
BEG Nasal Spray
Leading mold and biotoxin physicians recommend BEG compounded nasal spray as an effective way to eliminate biofilm forming, antibiotic-resistant staphylococcus colonizations in the sinus cavity related to MARCoNS. BEG nasal spray is used to treat patients susceptible to chronic and recurring staph infections. This unique formulation addresses the needs of patients recovering from sinus infections and biotoxin illnesses. Laboratory studies have shown topical antibiofilm treatment to be an effective option to combat antibiotic-resistant bacterial colonies. This is a key step aiding in the recovery and healing process. BEG nasal spray’s active ingredients are a combination of two antibiotics Bactroban (mupirocin) and Gentamicin and a calcium chelator, Edetate Disodium (EDTA). Topical antibiotics have been widely used in the treatment of biofilm due to its easy administration and minimal systemic adverse effects. In a clinical trial on the efficacy of topical Bactroban (mupirocin) treatment in the sinuses of chronic sinusitis (CRS) patients, it was concluded that mupirocin could be useful in eliminating Staphylococcus aureus (S. aureus) biofilms present on the sinus mucosa of CRS patients and offer an additional treatment method for patients with recurring sinusitis. EDTA dissolves the biofilm coating in the nasal cavity, allowing the topical antibiotics/antifungals to target the infection.
Combination nasal sprays are the drugs of choice by top doctors and practitioners to treat fungal sinusitis. Forte Rx Compounding Pharmacy specializes in compounded medications for the treatment of chronic inflammatory response syndrome (CIRS), sinus, mold/biotoxin-related illnesses, MCAS, and Lyme Disease. We go out of our way to ensure the safety of patients and only source ingredients that meet industry standards.
Please contact our clinical department today at (805) 427-9053 and ask to speak with one of our expert CIRS, mold/biotoxin illness, MCAS, sinus, and Lyme Disease clinical pharmacists about BEG Nasal Spray.
[17] Dr. Shoemaker’s 11-Step Treatment for Biotoxin Illness https://www.wondermakers.com/Portals/0/11-Step%20Treatment%20for%20Biotoxin%20Illness.pdf
Brewer, J. H., Hooper, D., & Muralidhar, S. (2015). Intranasal antifungal therapy in patients with chronic illness associated with mold and mycotoxins: An observational analysis. Global Journal of Medical Research, 15, 29-33.
[18] Dr. Shoemaker’s 11-Step Treatment for Biotoxin Illness
[19] Le, T., Psaltis, A., Tan, L. W., & Wormald, P.-J. (2008). The Efficacy of Topical Antibiofilm Agents in a Sheep Model of Rhinosinusitis. American Journal of Rhinology, 22(6), 560–567. https://doi.org/10.2500/ajr.2008.22.3232
[20] Goh, Y. H., & Goode, R. L. (2000). State of the Art Review: Current Status of topical nasal antimicrobial agents. The Laryngoscope, 110(6), 875–880. https://doi.org/10.1097/00005537-200006000-00001
[21] Ha KR, Psaltis AJ, Butcher AR, Wormald PJ, Tan LW. In vitro activity of mupirocin on clinical isolates of Staphylococcus aureus and its potential implications in chronic rhinosinusitis. Laryngoscope. 2008 Mar;118(3):535-40. doi: 10.1097/MLG.0b013e31815bf2e3. PMID: 18090864.
[22] Dr. Shoemaker’s 11-Step Treatment for Biotoxin Illness https://www.wondermakers.com/Portals/0/11-Step%20Treatment%20for%20Biotoxin%20Illness.pdf